Neuropsychopharmacology
- Escalation of cocaine consumption: tolerance versus sensitization of incentive salience3 months ago
- Risk calculation circuit abnormalities plus psychosocial risk variables predict problematic substance use in youth with externalizing disorders3 months ago
- Comparing affective bias modification by first- and second-generation antidepressants in male rats using a translational behavioural task3 months ago
- The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controls3 months ago
- The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder3 months ago
- Sensorimotor circuit connectivity as a candidate biomarker for responsiveness to sertraline in obsessive–compulsive disorder3 months ago
- Transcriptional profiles of antidepressant resistance across the corticolimbic pathway of chronically stressed mice3 months ago
Journal of Psychopharmacology
- The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research5 months ago
- Farewell to Jim Watson (and Francis Crick). A reflection on their contributions to psychiatry and brain science5 months ago
- Efficacy and safety of pharmacological and non-pharmacological interventions for antipsychotic-induced weight gain in individuals with schizophrenia: A systematic review and network meta-analysis of 55 clinical trials5 months ago
- Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review6 months ago
- Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review6 months ago
- Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations6 months ago
- The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications6 months ago
European Neuropsychopharmacology
- Association of antipsychotic nonadherence with all-cause mortality in adults with schizophrenia newly treated or reinitiating antipsychotic medication: A retrospective healthcare claims study5 months ago
- Prescribing clozapine to 10% of patients with schizophrenia may save 320,000 lives and cost 2400 deaths from agranulocytosis5 months ago
- A European perspective on tardive dyskinesia5 months ago
- All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hong Kong5 months ago
- Efficacy of xanomeline and xanomeline trospium in the treatment of cognitive impairment: A systematic review of preclinical and clinical trials5 months ago
- Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study5 months ago
- Ayahuasca modulation of traumatic-like fear memories requires infralimbic cortex BDNF-dependent mechanisms in rats5 months ago